New York, NY -- (SBWIRE) -- 12/26/2013 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: Whole Foods Market, Inc (NASDAQ:WFM), Celgene Corporation (NASDAQ:CELG), SLM Corp (NASDAQ:SLM), Responsys Inc (NASDAQ:MKTG)
Whole Foods Market, Inc (NASDAQ:WFM) showed a volume of 825,250.00 shares by the end of last trade whereas the average volume of the stock remained 2.87 million shares. The stock opened the session at $57.97 but then moved to $57.99. At that price, the stock showed a positive performance of 0.07%. Whole Foods Market, Inc. (Whole Foods Market) is a natural and organic foods supermarkets. As of September 25, 2011, Whole Foods Market operated 311 stores in the United States, Canada, and the United Kingdom. The Company’s stores average 38,000 square feet in size and 10 years in age, and are supported by its Austin headquarters, regional offices, distribution centers, bakehouse facilities, commissary kitchens, seafood-processing facilities, meat and produce procurement centers, and a specialty coffee, tea procurement and roasting operation. As of September 25, 2011,
Will WFM Continue To Move Higher? Find Out Here
Celgene Corporation (NASDAQ:CELG) opened the session at $167.69 and closed the session at $167.42. The stock showed a negative performance of -0.55% in previous trading session. Traded with volume of 820,230.00 shares in the prior session and the average volume of the stock remained 2.71 million shares. Celgene Corporation is a global biopharmaceutical company engaged in the discovery, development and commercialization of therapies designed to treat cancer and immune-inflammatory related diseases. It is engaged in the research and development, which is designed to bring new therapies to market, and is engaged in research in several scientific areas that may deliver therapies, focusing areas, such as intracellular signaling pathways in cancer and immune cells, immunomodulation in cancer and autoimmune diseases, and therapeutic application of cell therapies.
Has CELG Found The Bottom And Ready To Gain Momentum? Find Out Here
SLM Corp (NASDAQ:SLM) opened the session at $25.92 and closed the session at $26.05. The stock showed a positive performance of 0.39% in previous trading session. Traded with volume of 816,778.00 shares in the prior session and the average volume of the stock remained 3.09 million shares. The beta of the stock remained 1.18. SLM Corporation (Sallie Mae) is a holding company. It operates in three business segments: Consumer Lending, Business Services and FFELP Loans. The fourth segment includes Other. The Company’s primary business is to originate, service and collect loans it makes to students and their families to finance the cost of their education. It uses Private Education Loans to mean education loans to students or their families that are non-federal loans and loans not insured or guaranteed under the previously existing Federal Family Education Loan Program (FFELP).
Why Should Investors Buy SLM After The Recent Gain? Just Go Here and Find Out
Responsys Inc (NASDAQ:MKTG) the stock advanced 0.55% and finished the session at $27.45. Traded with volume of 810,306.00 shares in the prior session and the average volume of the stock remained 1.31 million shares. Responsys, Inc. (Responsys) is a provider of on-demand software and professional services. The Company’s offering, the Responsys Interact Suite, provides marketers with a range of integrated applications to create, execute, optimize and automate marketing campaigns across the interactive channels, such as e-mail, mobile, social and the Web.
Will MKTG Continue To Move Higher? Find Out Here
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)